P1168: CHARACTERISTICS PREDICTIVE OF PROGRESSION DURING FRONTLINE TREATMENT IN AGGRESSIVE B-CELL LYMPHOMAS

• A. Bock,
• R. Mwangi,
• M. Maurer,
• J. Cerhan,
• W. L. Ng,
• R. King,
• N. N. Bennani,
• S. Ansell,
• T. Habermann,
• T. Witzig,
• Y. Wang,
• G. Nowakowski

Affiliations

A. Bock

1 Division of Hematology

R. Mwangi

2 Division of Biostatistics

M. Maurer

2 Division of Biostatistics

J. Cerhan

3 Division of Epidemiology, Department of Quantitative Health Sciences

W. L. Ng

1 Division of Hematology

R. King

4 Department of Pathology, Mayo Clinic, Rochester, United States of America

N. N. Bennani

1 Division of Hematology

S. Ansell

1 Division of Hematology

T. Habermann

1 Division of Hematology

T. Witzig

1 Division of Hematology

Y. Wang

1 Division of Hematology

G. Nowakowski

1 Division of Hematology